What Analysts Are Saying About Health Catalyst Stock
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Health Catalyst (NASDAQ:HCAT) over the past three months, with most being somewhat bullish. The average 12-month price target has slightly increased to $13.12. Analysts have adjusted their ratings and price targets, reflecting their evolving views on the company's performance.
October 08, 2024 | 7:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Health Catalyst has received mixed analyst ratings, with a majority being somewhat bullish. The average price target has increased slightly, indicating a positive outlook. Analysts have adjusted their ratings and price targets, reflecting their evolving views on the company's performance.
The majority of analysts are somewhat bullish on Health Catalyst, with a slight increase in the average price target. This suggests a positive short-term outlook. The adjustments in ratings and price targets by analysts indicate their evolving views, which could influence investor sentiment positively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100